- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Revlimid
Total 586 results
-
John ReneauActive, not recruitingRecurrent T-Cell Non-Hodgkin Lymphoma | Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma | Stage IV Cutaneous T-Cell Non-Hodgkin Lymphoma | Primary Cutaneous Anaplastic Large Cell Lymphoma | Refractory Primary Cutaneous T-Cell Non-Hodgkin... and other conditionsUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNovartis; Celgene CorporationActive, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Weill Medical College of Cornell UniversityCelgene CorporationTerminated
-
GWT-TUD GmbHAstraZeneca; CelgeneActive, not recruitingPancreatic Adenocarcinoma | Pancreatic Ductal Adenocarcinoma | Pancreas CancerGermany
-
Cristina GasparettoCelgene CorporationCompletedMultiple MyelomaUnited States
-
IRCCS Policlinico S. MatteoCelgene CorporationCompleted
-
Mayo ClinicNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
OncotherapeuticsIncyte CorporationNot yet recruiting
-
OncotherapeuticsIncyte CorporationRecruitingMultiple MyelomaUnited States
-
Abramson Cancer Center at Penn MedicineCompletedFollicular Lymphoma | Waldenstrom Macroglobulinemia | Mantle-Cell Lymphoma | Lymphoma, Small Lymphocytic | Marginal Zone B-Cell Lymphoma | MALT Lymphoma | Lymphoma of Mucosa-Associated Lymphoid TissueUnited States
-
M.D. Anderson Cancer CenterNovartisCompleted
-
Case Comprehensive Cancer CenterTerminatedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditionsUnited States
-
SanofiCompleted
-
Hackensack Meridian HealthActive, not recruitingMultiple MyelomaUnited States
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH); Millennium... and other collaboratorsActive, not recruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Sun Yat-sen UniversityChina Food and Drug AdministrationWithdrawnRelapse/Refractory Multiple MyelomaChina
-
University of Alabama at BirminghamJanssen Scientific Affairs, LLC; AmgenCompletedMultiple MyelomaUnited States
-
Swiss Group for Clinical Cancer ResearchTerminatedMultiple MyelomaSwitzerland, Italy
-
University of AthensHellenic Cooperative Oncology GroupCompleted
-
Bristol-Myers SquibbAbbVieCompleted
-
Bristol-Myers SquibbCompleted
-
M.D. Anderson Cancer CenterCelgene Corporation; The Leukemia and Lymphoma SocietyCompleted
-
Roswell Park Cancer InstituteCelgeneActive, not recruitingPlasma Cell Myeloma | Partial Response of Multiple Myeloma or Plasma Cell LeukemiaUnited States
-
Bristol-Myers SquibbAbbVieCompletedMultiple MyelomaUnited States, Australia, Austria, Belgium, Canada, Czechia, Germany, Greece, Hungary, Ireland, Israel, Italy, Poland, Puerto Rico, Romania, Russian Federation, Spain, Switzerland, Turkey, United Kingdom
-
Bristol-Myers SquibbAbbottTerminatedNewly Diagnosed, Previously Untreated Multiple MyelomaUnited States, Poland, Italy, Greece
-
H. Lee Moffitt Cancer Center and Research InstituteNovartis; Celgene CorporationCompletedChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Gilead SciencesCompletedMantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Indolent Non-Hodgkin's LymphomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteCelgene Corporation; Ortho Biotech Clinical Affairs, L.L.C.CompletedMultiple MyelomaUnited States
-
M.D. Anderson Cancer CenterPfizerNot yet recruitingMultiple Myeloma | Post-transplant MRD-guided Maintenance Therapy | Pre-transplant PurgingUnited States
-
Bristol-Myers SquibbAbbVieCompletedLymphoma | Multiple MyelomaUnited States, Belgium, France, Germany, Italy, Japan, United Kingdom, Australia, Poland, Puerto Rico, Canada, Denmark, Hungary, Israel, Spain, Czechia, Ireland, Austria, Switzerland, Greece, Turkey, Romania, United Arab Emirates
-
National Cancer Institute (NCI)CompletedStage II Multiple Myeloma | Stage III Multiple Myeloma | Multiple Myeloma in RelapseUnited States
-
Weill Medical College of Cornell UniversityOnyx Therapeutics, Inc.Active, not recruiting
-
Mayo ClinicCompletedRefractory Multiple MyelomaUnited States
-
National University Hospital, SingaporeNational University of SingaporeRecruiting
-
Washington University School of MedicineMillennium Pharmaceuticals, Inc.; Multiple Myeloma Research ConsortiumActive, not recruiting
-
PrECOG, LLC.CelgeneTerminatedMultiple Myeloma | Plasma Cell NeoplasmUnited States
-
M.D. Anderson Cancer CenterCompletedSolid TumorsUnited States
-
OncotherapeuticsAmgenTerminatedMultiple MyelomaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...TerminatedMultiple MyelomaUnited States
-
Stanford UniversityNational Cancer Institute (NCI)TerminatedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute... and other conditionsUnited States
-
PETHEMA FoundationCelgene; Pierre Fabre Medicament; Janssen, LPCompleted
-
Bristol-Myers SquibbAbbVieActive, not recruitingMultiple MyelomaUnited States, Canada, Australia, Poland, Italy, Belgium, Spain, Japan, Greece, Hungary, Romania, Turkey, United Kingdom
-
University of Southern CaliforniaNational Cancer Institute (NCI); Celgene CorporationTerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States
-
University of LeedsCelgene; Janssen, LP; Myeloma UKActive, not recruiting
-
M.D. Anderson Cancer CenterCelgene CorporationTerminatedChronic Lymphocytic LeukemiaUnited States
-
The Lymphoma Academic Research OrganisationActive, not recruitingMantle Cell LymphomaFrance, Spain, Belgium, Netherlands, Germany, Poland, Portugal
-
Mayo ClinicCompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States
-
University of LeedsTakeda; Cancer Research UK; CelgeneRecruitingMultiple MyelomaUnited Kingdom
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAnn Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage III Indolent Adult Non-Hodgkin Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Indolent Adult Non-Hodgkin... and other conditionsUnited States
-
Gesellschaft fur Medizinische Innovation - Hamatologie...Celgene; AmgenTerminatedDiffuse Large B-cell Lymphoma (DLBCL) | Burkitt Lymphoma (BL) | Follicular Lymphoma Grade III (FL III°) | Mantle Cell Lymphoma (MCL), Blastoid Variant | Aggressive Marginal Zone Lymphoma (MZL)Germany